Tuesday's Top 6 Pre-Market Gainers Explained
June 07, 2016 at 10:09 AM EDT
Sarepta Therapeutics Inc (NASDAQ: SRPT) was up 28.97 percent after the FDA requested Dystrophin data prior to making a decision on ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.